Anti-MAG Autoantibodies ELISA Archives - Page 3 of 3 - Buhlmann Diagnostics Corp

Tag: Anti-MAG Autoantibodies ELISA

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Anti-MAG Autoantibodies ELISA Citation: Ferfoglia R I et al.; Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study; Journal of the Peripheral Nervous System 21:10–14 (2016)PMID:26748872 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citations: Stork AC et al.; Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2016 Jan 15; 290:76-9. PMID:26711574 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading